trending Market Intelligence /marketintelligence/en/news-insights/trending/4ya7ciak1jcdbfj-htiqyw2 content esgSubNav
In This List

Retrophin CEO plans to retire

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Retrophin CEO plans to retire

Retrophin Inc. said Stephen Aselage plans to retire as CEO.

Aselage, who has been CEO since November 2014, will step down after the company identifies his successor.

Retrophin's board has initiated a global search for his successor that will include both internal and external candidates.

San Diego, Calif.-based Retrophin develops treatments for serious or rare diseases. Martin Shkreli, who was convicted of securities fraud in March, is the company's co-founder and former CEO.